Bbva Compass Bancshares Inc. lessened its stake in AmerisourceBergen Corp. (NYSE:ABC) by 5.7% during the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 30,002 shares of the company’s stock after selling 1,806 shares during the quarter. Bbva Compass Bancshares Inc.’s holdings in AmerisourceBergen were worth $2,559,000 as of its most recent filing with the SEC.

Several other institutional investors also recently modified their holdings of the company. River Wealth Advisors LLC raised its stake in AmerisourceBergen by 1.6% during the first quarter. River Wealth Advisors LLC now owns 34,764 shares of the company’s stock worth $2,997,000 after acquiring an additional 561 shares during the period. State Treasurer State of Michigan raised its stake in AmerisourceBergen by 1.3% during the first quarter. State Treasurer State of Michigan now owns 47,884 shares of the company’s stock worth $4,128,000 after acquiring an additional 600 shares during the period. Bronfman E.L. Rothschild L.P. raised its stake in AmerisourceBergen by 54.8% during the first quarter. Bronfman E.L. Rothschild L.P. now owns 1,698 shares of the company’s stock worth $146,000 after acquiring an additional 601 shares during the period. Donald L. Hagan LLC raised its stake in AmerisourceBergen by 3.9% during the second quarter. Donald L. Hagan LLC now owns 16,681 shares of the company’s stock worth $1,422,000 after acquiring an additional 622 shares during the period. Finally, Quadrant Capital Group LLC raised its stake in AmerisourceBergen by 34.9% during the first quarter. Quadrant Capital Group LLC now owns 2,460 shares of the company’s stock worth $206,000 after acquiring an additional 637 shares during the period. Institutional investors and hedge funds own 66.64% of the company’s stock.

In other AmerisourceBergen news, insider Kathy H. Gaddes sold 2,652 shares of the company’s stock in a transaction dated Wednesday, June 20th. The shares were sold at an average price of $92.03, for a total value of $244,063.56. Following the completion of the transaction, the insider now owns 3,891 shares in the company, valued at approximately $358,088.73. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CFO Tim G. Guttman sold 11,600 shares of the company’s stock in a transaction dated Friday, June 1st. The stock was sold at an average price of $80.83, for a total transaction of $937,628.00. Following the completion of the transaction, the chief financial officer now owns 51,189 shares of the company’s stock, valued at approximately $4,137,606.87. The disclosure for this sale can be found here. In the last 90 days, insiders sold 102,682 shares of company stock valued at $8,546,719. 27.30% of the stock is owned by insiders.

NYSE ABC opened at $82.14 on Tuesday. AmerisourceBergen Corp. has a 52 week low of $71.90 and a 52 week high of $106.27. The company has a quick ratio of 0.48, a current ratio of 0.94 and a debt-to-equity ratio of 1.28. The stock has a market capitalization of $17.80 billion, a price-to-earnings ratio of 13.86, a PEG ratio of 1.26 and a beta of 1.00.

AmerisourceBergen (NYSE:ABC) last posted its earnings results on Thursday, August 2nd. The company reported $1.54 EPS for the quarter, topping the consensus estimate of $1.46 by $0.08. AmerisourceBergen had a net margin of 0.69% and a return on equity of 48.65%. The firm had revenue of $43.14 billion during the quarter, compared to analysts’ expectations of $43.05 billion. During the same quarter in the prior year, the firm earned $1.43 EPS. AmerisourceBergen’s quarterly revenue was up 11.4% on a year-over-year basis. equities analysts expect that AmerisourceBergen Corp. will post 6.48 earnings per share for the current year.

ABC has been the topic of several research reports. Morgan Stanley dropped their price objective on shares of AmerisourceBergen from $97.00 to $88.00 and set an “equal weight” rating on the stock in a research note on Tuesday, July 3rd. ValuEngine upgraded shares of AmerisourceBergen from a “sell” rating to a “hold” rating in a research note on Saturday, June 16th. Robert W. Baird reiterated a “hold” rating and set a $89.00 price objective on shares of AmerisourceBergen in a research note on Friday. Finally, Zacks Investment Research lowered shares of AmerisourceBergen from a “hold” rating to a “sell” rating in a research note on Thursday, April 12th. Two research analysts have rated the stock with a sell rating, six have issued a hold rating and nine have given a buy rating to the company. AmerisourceBergen currently has an average rating of “Hold” and an average price target of $102.47.

AmerisourceBergen Profile

AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers.

See Also: Are Wall Street analysts’ stock ratings worth following?

Want to see what other hedge funds are holding ABC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AmerisourceBergen Corp. (NYSE:ABC).

Institutional Ownership by Quarter for AmerisourceBergen (NYSE:ABC)

Receive News & Ratings for AmerisourceBergen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen and related companies with MarketBeat.com's FREE daily email newsletter.